Women-founded companies are breaking the mold on the Central Coast
Growing up, Blanca Hoffmeir loved aviation. As an adult, she became an engineer and worked her way up from a small company to a larger one. The larger company used drones for surveying purposes and, because she had her private pilot license, Hoffmeir was asked to be onboarded as a drone pilot to provide services Read More →
Transphorm bought out in $339M deal
Goleta-based Transphorm, a spinout from UC Santa Barbara, was purchased by Renesas Electronics Corporation on Jan. 10 in a deal worth approximately $339 million. Tokyo-based Renesas is a supplier of advanced semiconductor solutions while Transphorm is a leader in gallium nitride power semiconductors. According to details of the purchase, Renesas will acquire Transphorm for $5.10 Read More →
Geri LaChance, SESLOC CEO, retiring in June
Geri LaChance, president and CEO of the SESLOC Federal Credit Union for 12 years, is retiring effective June 2024, the San Luis Obispo-based nonprofit announced Jan. 10. She will be succeeded by Mike Quamma, the organization’s executive vice president and CFO. SESLOC Board Chair Tom Lebens praised LaChance’s tenure. “It’s hard to aptly summarize the Read More →
Optimism is high for tri-county travel sector in ‘24
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
Generative AI will take off in 2024, area experts say
2024 will be the year of the new wave of artificial intelligence — generative AI — Tri-County experts in the field say. Most, if not all, AI companies and other businesses that use AI will be dialing into the cutting-edge technology more and more, the specialists say. They include those in the Central Coast region Read More →
MannKind inks royalty purchase agreement for up to $200M
Westlake Village-based MannKind Corporation saw shares climb 8% on Jan. 2 after the company announced entering into a royalty purchase agreement of up to $200 million. MannKind, a biotechnology company that develops treatments for diabetes and pulmonary arterial hypertension, sold a 1% royalty in net sales of Tyvaso DPI to Sagard Healthcare on Dec. 27. Read More →
Limoneira pleased by FY2023 despite revenue dip
Despite a 2.5% dip in fiscal year 2023 revenues compared to fiscal year 2022, the CEO of Santa Paula-based Limoneira says he’s pleased with the agribusiness’s year-over-year performance. “We achieved our full-year avocado and revised lemon volume guidance despite harsh weather conditions and softer lemon pricing throughout most of the year,” Harold Edwards said during Read More →
